Search Results - "DIENG SARR, Abdoulaye"

Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection by MACNEIL, Adam, DIENG SARR, Abdoulaye, SANKALE, Jean-Louis, THAKORE MELONI, Seema, MBOUP, Souleymane, KANKI, Phyllis

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Relationship between Human Immunodeficiency Type 1 Infection and Expression of Human APOBEC3G and APOBEC3F by Ulenga, Nzovu K, Sarr, Abdoulaye Dieng, Thakore-Meloni, Seema, Sankalé, Jean-Louis, Eisen, Geoff, Kanki, Phyllis J

“…Background. Human immunodeficiency virus type 1 (HIV-1)-infected individuals with a high viral set point progress to acquired immunodeficiency syndrome (AIDS)…”
Get full text

Comparison of Heterologous Neutralizing Antibody Responses of Human Immunodeficiency Virus Type 1 (HIV-1)- and HIV-2-Infected Senegalese Patients: Distinct Patterns of Breadth and Magnitude Distinguish HIV-1 and HIV-2 Infections by RODRIGUEZ, Shaun K, DIENG SARR, Abdoulaye, MACNEIL, Adam, THAKORE-MELONI, Seema, GUEYE-NDIAYE, Aissatou, TRAORE, Ibrahima, DIA, Mamadou C, MBOUP, Souleymane, KANKI, Phyllis J

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV-1 and HIV-2 by Popper, Stephen J., Sarr, Abdoulaye Dieng, Travers, Karin U., Guèye-Ndiaye, Aissatou, Mboup, Souleymane, Essex, Myron E., Kanki, Phyllis J.

“…Human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV type 1 (HIV-1), but the mechanisms underlying this difference have not been defined. We…”
Get full text

Genomic Sites of Human Immunodeficiency Virus Type 2 (HIV-2) Integration: Similarities to HIV-1 In Vitro and Possible Differences In Vivo by MACNEIL, Adam, SANKALE, Jean-Louis, THAKORE MELONI, Seema, DIENG SARR, Abdoulaye, MBOUP, Souleymane, KANKI, Phyllis

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Long-Term Intrapatient Viral Evolution during HIV-2 Infection by MacNeil, Adam, Sankalé, Jean-Louis, Meloni, Seema Thakore, Sarr, Abdoulaye Dieng, Mboup, Souleymane, Kanki, Phyllis

“…Background. Disease progression and transmission of human immunodeficiency virus (HIV) type 2 are attenuated, compared with HIV-1, which is consistent with the…”
Get full text

Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo by Popper, Stephen J., Sarr, Abdoulaye Dieng, Guèye-Ndiaye, Aïssatou, Mboup, Souleymane, Essex, Myron E., Kanki, Phyllis J.

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Viral Dynamics of Primary HIV-1 Infection in Senegal, West Africa by Sarr, Abdoulaye Dieng, Eisen, Geoffrey, Guèye-Ndiaye, Aïssatou, Mullins, Christopher, Traoré, Ibrahima, Dia, Mamadou Ciré, Sankalé, Jean-Louis, Faye, Diegane, Mboup, Souleymane, Kanki, Phyllis

“…BackgroundFew studies have addressed primary human immunodeficiency virus (HIV) type 1 infection in sub-Saharan Africa, where the epidemic is of a…”
Get full text

The Absence of Anti-Tat Antibodies Is Associated with Risk of Disease Progression in HIV-2 Infection by Rodriguez, Shaun K., Sarr, Abdoulaye Dieng, Olorunnipa, Olushola, Popper, Stephen J., Gueye-Ndiaye, Aissatou, Traoré, Ibrahima, Dia, Mamadou C., Mboup, Souleymane, Kanki, Phyllis J.

“…The Tat protein of human immunodeficiency virus (HIV) is essential for viral replication and has extracellular pathogenic activity. We sought to determine…”
Get full text

The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals by Ulenga, Nzovu K, Sarr, Abdoulaye Dieng, Hamel, Donald, Sankale, Jean-Louis, Mboup, Souleymane, Kanki, Phyllis J

“…The APOBEC family of mammalian cytidine deaminases, such as APOBEC3G (hA3G), has been demonstrated to function as a host viral restriction factor against…”
Get more information

Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response by Ojesina, Akinyemi I, Sankalé, Jean-Louis, Odaibo, Georgina, Langevin, Stanley, Meloni, Seema T, Sarr, Abdoulaye Dieng, Olaleye, David, Kanki, Phyllis J

“…As the use of antiretroviral therapy becomes more widespread across Africa, it is imperative to characterize baseline molecular variability and…”
Get more information

Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection by Hanson, Andrea, Sarr, Abdoulaye Dieng, Shea, Amy, Jones, Norman, Mboup, Souleymane, Kanki, Phyllis, Cao, Huyen

“…The mechanism for the lower rate of disease progression in HIV-2 infection remains undefined. We evaluated T cell activation in a cohort of HIV-infected…”
Get more information

Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection by Mullins, Christopher, Eisen, Geoffrey, Popper, Stephen, Sarr, Abdoulaye Dieng, Sankalé, Jean-Louis, Berger, Judith J., Wright, Sharon B., Chang, Hernan R., Coste, Gérard, Cooley, Timothy P., Rice, Peter, Skolnik, Paul R., Sullivan, Margaret, Kanki, Phyllis J.

“…Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause AIDS, is endemic to West Africa but is infrequently found outside this…”
Get full text

Natural Protection Against HIV-1 Infection Provided by HIV-2 by Travers, Karin, Mboup, Souleymane, Marlink, Richard, Guèye-Ndiaye, Aissatou, Siby, Tidiane, Thior, Ibou, Traore, Ibrahima, Dieng-Sarr, Abdoulaye, Sankalé, Jean-Louis, Mullins, Christopher, Ndoye, Ibrahima, Hsieh, Chung-Cheng, Essex, Max, Kanki, Phyllis

“…Significant differences have been observed in the rates of transmission and disease development in human immunodeficiency virus (HIV) types 1 and 2. Because…”
Get full text

Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals by Dieye, Tandakha Ndiaye, Sow, Papa Salif, Simonart, Thierry, Guèye-Ndiaye, Aı̈ssatou, Popper, Stephen J, Delforge, Marie-Luce, Dieye, Alioune, Sarr, Abdoulaye Dieng, Crusiaux, Alain, Vooren, Jean-Paul Van, Devleeschouwer, Michel, Kanki, Phyllis, Mboup, Souleymane, Diakhate, Lamine, Farber, Claire-Michèle

“…Twelve HIV-1-infected, nine HIV-2-infected patients and eight HIV-negative subjects were given a 40 IU booster dose of tetanus toxoid (TT). Blood was collected…”
Get full text

Genetic analysis of HIV type 2 in monotypic and dual HIV infections by Sarr, A D, Sankalé, J L, Guèye-Ndiaye, A, Essex, M, Mboup, S, Kanki, P J

“…A significant level of genetic variation among HIV-1 and HIV-2 has been described. The interaction of specific HIV-2 subtypes with HIV-1 may serve to identify…”
Get more information

Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings by Rawizza, Holly E., Chaplin, Beth, Meloni, Seema T., Eisen, Geoffrey, Rao, Tara, Sankalé, Jean-Louis, Dieng-Sarr, Abdoulaye, Agbaji, Oche, Onwujekwe, Daniel I., Gashau, Wadzani, Nkado, Reuben, Ekong, Ernest, Okonkwo, Prosper, Murphy, Robert L., Kanki, Phyllis J.

“…Among 9690 individuals receiving antiretroviral therapy in Nigeria, almost 50% of those identified as having treatment failure by CD4 cell criteria were…”
Get full text

Robust HIV type 2 cellular immune response measured by a modified anthrax toxin-based enzyme-linked immunospot assay by Sarr, A D, Lu, Y, Sankalé, J L, Eisen, G, Popper, S, Mboup, S, Kanki, P J, Cao, H

“…Evaluation of immune mechanisms responsible for control of viral replication is critical to understanding HIV-2 attenuated biological characteristics in…”
Get more information

A 5′UTR-Spliced mRNA Isoform Is Specialized for Enhanced HIV-2 gag Translation by Strong, Christy L., Lanchy, Jean-Marc, Dieng-Sarr, Abdoulaye, Kanki, Phyllis J., Lodmell, J. Stephen

“…Full-length unspliced genomic RNA plays critical roles in HIV replication, serving both as mRNA for the synthesis of the key viral polyproteins Gag and Gag-Pol…”
Get full text

Immunologie Criteria Are Poor Predictors of Virologie Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings by Rawizza, Holly E., Chaplin, Beth, Meloni, Seema T., Eisen, Geoffrey, Rao, Tara, Sankalé, Jean-Louis, Dieng-Sarr, Abdoulaye, Agbaji, Oche, Onwujekwe, Daniel I., Gashau, Wadzani, Nkado, Reuben, Ekong, Ernest, Okonkwo, Prosper, Murphy, Robert L, Kanki, Phyllis J.

“…Background. Viral load (VL) quantification is considered essential for determining antiretroviral treatment (ART) success in resource-rich countries. However,…”
Get full text